Artemisinin
- Generic Name
- Artemisinin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H22O5
- CAS Number
- 63968-64-9
- Unique Ingredient Identifier
- 9RMU91N5K2
- Background
Artemisinin has been used in trials studying the treatment of Schizophrenia, Malaria, Falciparum, and Plasmodium Falciparum.
- Associated Conditions
- Malaria caused by Plasmodium falciparum
- Associated Therapies
- -
A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2021-03-16
- Lead Sponsor
- Oncotelic Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT04801017
- Locations
- 🇧🇷
Praxis Pesquisa Medica S / S Ltda, Jardim, Brazil
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- Beijing HuiLongGuan Hospital
- Target Recruit Count
- 88
- Registration Number
- NCT01391403
- Locations
- 🇨🇳
Beijing HuiLongGuan hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath